The state Supreme Court’s denial Thursday of a drug manufacturer’s request to hear more than a dozen hormone-replacement therapy tort cases could keep hundreds of cases on the Philadelphia Common Pleas Court’s dockets.
When the state Superior Court overturned Philadelphia Common Pleas Court Judge Allan L. Tereshko’s grant of summary judgment in favor of Wyeth Pharmaceuticals and Pharmacia & Upjohn in 14 consolidated cases, the intermediate court said it is a question of fact, not a question of law, whether the plaintiffs could have known at the time of their diagnoses with breast cancer that the alleged cause of their cancer was their HRT prescriptions.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
